⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24673925 | 0.50 | — | — | |
| SCHEMBL7106578 | 0.49 | — | — | |
| SCHEMBL22295854 | 0.49 | — | — | |
| SCHEMBL17846809 | 0.45 | GSK3A (0.32) | — | |
| SCHEMBL369355 | 0.45 | — | — | |
| SCHEMBL4453014 | 0.43 | MEN1 (1.00) | — | |
| SCHEMBL9596236 | 0.43 | — | — | |
| SCHEMBL11985917 | 0.43 | KDM4E (0.31) | — | |
| SCHEMBL895221 | 0.42 | — | — | |
| SCHEMBL15484301 | 0.40 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102216292-B | Tetrasubstituted pyridazines HEDGEHOG pathway antagonists | LILLY CO ELI | 2014-08-13 | — | — | CN | disclosed |
| EP-2358703-B1 | TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS | LILLY CO ELI (US) | 2013-12-25 | — | — | EP | disclosed |
| US-8445493-B2 | Tetrasubstituted pyridazines hedgehog pathway antagonists | ELI LILLY AND COMPANY (US) | 2013-05-21 | — | — | US | disclosed |
| EP-2358703-A1 | TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS | Eli Lilly and Company (US) | 2011-08-24 | — | — | EP | disclosed |
| US-20110178093-A1 | TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2011-07-21 | — | — | US | disclosed |
| WO-2010056620-A1 | TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2010-05-20 | — | — | WO | disclosed |